Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 7 trials

Late-Stage Pipeline

29%

2 trials in Phase 3/4

Results Transparency

0 of 0 completed trials have results

Key Signals

2 recruiting

Enrollment Performance

Analytics

Phase 4

1(33.3%)

Phase 3

1(33.3%)

N/A

1(33.3%)

3Total

Phase 4(1)

Phase 3(1)

N/A(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (7)

Showing 7 of 7 trials

NCT06541106Recruiting

Registry of Endovascular Treatment for Vertebrobasilar Dissecting Aneurysms in China

Role: collaborator

NCT05342233Recruiting

Comparison of Conservative and Endovascular Treatment for Spontaneously Isolated Superior Mesenteric Artery Dissection

Role: collaborator

NCT04813445Not ApplicableUnknown

Analysing the Effects of Xingnaojing for Mild-to-severe Acute Ischemic Stroke

Role: collaborator

NCT04982380Phase 4Unknown

Efficacy and Safety of Bifidobacterium Quadruple Live Tablets in Patients With T2DM and Constipation

Role: collaborator

NCT04958447Unknown

Nutritional Management in Respiratory Critically Ill Patients -an Observational Study in Mainland China

Role: collaborator

NCT03733002Phase 3Unknown

Efficacy and Safety of AngongNiuhuang Pill for the Treatment of Patients With Acute Ischemic Stroke.

Role: collaborator

NCT03417063Unknown

Intracranial Artery Stenosis Magnetic Resonance Imaging: Aetiology and Progression

Role: collaborator

All 7 trials loaded